Liver Biomarkers

Biomarker research represents an evolving area within hepatology. The main functions of the liver include detoxification, metabolism, bile secretion, hemopoietic blood storage and regulation of circulating blood volume, immune defense and regeneration.

Several biomarkers are used in the diagnosis and monitoring of liver injury and liver disease. They can provide information about oxidative stress, nuclear damage, the mode of cell death, inflammation  and mitochondrial.

AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:

Alanine Aminotransferase (ALT/GPT)
Monoamine Oxidase (MAO)
Alkaline Phosphatase (ALP)
Lactate Dehydrogenase (LDH)
Cholinesterase (CHE)
Albumin (ALB)
Gamma-Glutamyl Transferase (y-GT)
Blood Ammonia
Biuret Protein
Bradford Protein
Total Bile Acid (TBA)
5'-Nueleotidase (5'-NT)
Adenosine Deaminase (ADA)
Alanine Aminotransferase (ALT/GPT)
Aspartate Aminotransferase (AST/GOT)
Glutathione-S-Transferase (GST)
Leucine Aminopeptidase (LAP)
Total Bilirubin (TBIL)
Direct Bilirubin (DBIL)
C-reactive protein (CRP)

Kidney Biomarkers

Kidney function refers to the function of kidney excreting metabolic waste, maintaining the stability of sodium, potassium, calcium and other electrolytes and the function of acid-base balance. Kidney function estimation was commonly made using serum creatinine concentration, blood urea nitrogen (BUN) level and urine analysis.

There are two types of kidney disorders: Acute kidney injury (AKI) and chronic kidney disease (CKD). Their diagnosis relies on biomarkers that assess kidney function.

AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:

Uric Acid (UA)
Creatinine (Cr)
Urea (BUN)
Oxalate
Oxalic Acid

Cancer Biomarkers

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. Biomarker testing helps characterize alterations in the tumor.

There is a lot of focus on developing new targeted therapy drugs that disrupt key drivers of cancer growth. Cancer biomarker research focuses on four areas:

    • Immunotherapy response
    • Liquid biopsies
    • Minimal residual disease
    • Pharmacodynamic markers

AMSBIO is offering an extensive range of products involved in this metabolic pathway as follows:

Human Epidermal Growth Factor Receptor 2 (HER 2)
Progesterone Receptors (PGR)
Breast Cancer Type 1 (BRCA1)
Estrogen Receptor (ER)
Breast Cancer Type 2 (BRCA2)
Tumor Protein 53 (TP53)
Prostate Stem Cell Antigen (PSCA)
Urokinase Plasminogen Activator (uPA)
Akt Kinase
EGFR1

Other Biomarkers

AMSBIO is offering an extensive range of other biomarkers involved in this metabolic pathway as follows:

Hemoglobin (Hgb)
Thyroid-stimulating hormone (TSH)
Triglycerides